Method
CA 2333159 A1 · Owner: Altman, Amnon · Inventors: Mustelin, Thomas; Sundvold, Vibeke; Tasken, Kjetil
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to methods of altering the activity of the PKA signaling pathway by altering, preferably inhibiting the extent of phosphorylation of , PKA substrates or downstream kinase substrates particularly by the use of , modified substrates gene sequences encoding such modified substrates vectors , and host cells containing the gene sequence inhibitors of substrate , phosphorylation and use of the gene sequence protein or inhibitors to alter , the PKA signaling pathway for example in treating immunosuppressive disorders or proliferative diseases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 27, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 27, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 27, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.